BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36207468)

  • 1. Pharmacokinetics and Pharmacodynamics of TAK-164 Antibody Drug Conjugate Coadministered with Unconjugated Antibody.
    Menezes B; Khera E; Calopiz M; Smith MD; Ganno ML; Cilliers C; Abu-Yousif AO; Linderman JJ; Thurber GM
    AAPS J; 2022 Oct; 24(6):107. PubMed ID: 36207468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying ADC bystander payload penetration with cellular resolution using pharmacodynamic mapping.
    Khera E; Cilliers C; Smith MD; Ganno ML; Lai KC; Keating TA; Kopp A; Nessler I; Abu-Yousif AO; Thurber GM
    Neoplasia; 2021 Feb; 23(2):210-221. PubMed ID: 33385970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Agent-Based Systems Pharmacology Model of the Antibody-Drug Conjugate Kadcyla to Predict Efficacy of Different Dosing Regimens.
    Menezes B; Cilliers C; Wessler T; Thurber GM; Linderman JJ
    AAPS J; 2020 Jan; 22(2):29. PubMed ID: 31942650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Catabolism of [
    Bolleddula J; Shah A; Shadid M; Kamali A; Smith MD; Chowdhury SK
    Drug Metab Dispos; 2020 Nov; 48(11):1239-1245. PubMed ID: 32843329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulating the Selection of Resistant Cells with Bystander Killing and Antibody Coadministration in Heterogeneous Human Epidermal Growth Factor Receptor 2-Positive Tumors.
    Menezes B; Linderman JJ; Thurber GM
    Drug Metab Dispos; 2022 Jan; 50(1):8-16. PubMed ID: 34649966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Coadministration as a Strategy to Overcome Binding-Site Barrier for ADCs: a Quantitative Investigation.
    Singh AP; Guo L; Verma A; Wong GG; Thurber GM; Shah DK
    AAPS J; 2020 Jan; 22(2):28. PubMed ID: 31938899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systems Pharmacology Model for Drug Delivery to Solid Tumors by Antibody-Drug Conjugates: Implications for Bystander Effects.
    Burton JK; Bottino D; Secomb TW
    AAPS J; 2019 Dec; 22(1):12. PubMed ID: 31828446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Tumor Penetration and Single-Cell Targeting of Antibody-Drug Conjugates Increases Anticancer Efficacy and Host Survival.
    Cilliers C; Menezes B; Nessler I; Linderman J; Thurber GM
    Cancer Res; 2018 Feb; 78(3):758-768. PubMed ID: 29217763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of high avidity and low affinity antibodies for in situ control of antibody drug conjugate targeting.
    Evans R; Thurber GM
    Sci Rep; 2022 May; 12(1):7677. PubMed ID: 35538109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the Systems Pharmacokinetics-Pharmacodynamics Model for Antibody-Drug Conjugates to Characterize Tumor Heterogeneity and
    Singh AP; Seigel GM; Guo L; Verma A; Wong GG; Cheng HP; Shah DK
    J Pharmacol Exp Ther; 2020 Jul; 374(1):184-199. PubMed ID: 32273304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative characterization of in vitro bystander effect of antibody-drug conjugates.
    Singh AP; Sharma S; Shah DK
    J Pharmacokinet Pharmacodyn; 2016 Dec; 43(6):567-582. PubMed ID: 27670282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived Xenografts.
    Abu-Yousif AO; Cvet D; Gallery M; Bannerman BM; Ganno ML; Smith MD; Lai KC; Keating TA; Stringer B; Kamali A; Eng K; Koseoglu S; Zhu A; Xia CQ; Landen MS; Borland M; Robertson R; Bolleddula J; Qian MG; Fretland J; Veiby OP
    Mol Cancer Ther; 2020 Oct; 19(10):2079-2088. PubMed ID: 32788205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Evaluation of the Effect of Antigen Expression Level on Antibody-Drug Conjugate Exposure in Solid Tumor.
    Bussing D; Sharma S; Li Z; Meyer LF; Shah DK
    AAPS J; 2021 Apr; 23(3):56. PubMed ID: 33856579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models.
    Li F; Emmerton KK; Jonas M; Zhang X; Miyamoto JB; Setter JR; Nicholas ND; Okeley NM; Lyon RP; Benjamin DR; Law CL
    Cancer Res; 2016 May; 76(9):2710-9. PubMed ID: 26921341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody-Drug Conjugates to Increase
    Ponte JF; Lanieri L; Khera E; Laleau R; Ab O; Espelin C; Kohli N; Matin B; Setiady Y; Miller ML; Keating TA; Chari R; Pinkas J; Gregory R; Thurber GM
    Mol Cancer Ther; 2021 Jan; 20(1):203-212. PubMed ID: 33177153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Tumor Penetration of Single-Domain Antibody-Drug Conjugates Improves
    Nessler I; Khera E; Vance S; Kopp A; Qiu Q; Keating TA; Abu-Yousif AO; Sandal T; Legg J; Thompson L; Goodwin N; Thurber GM
    Cancer Res; 2020 Mar; 80(6):1268-1278. PubMed ID: 31941698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Modeling of Intra-Tumor Spatial Distribution of Antibody-Drug Conjugates: Insights into Dosing Strategies in Oncology.
    Weddell J; Chiney MS; Bhatnagar S; Gibbs JP; Shebley M
    Clin Transl Sci; 2021 Jan; 14(1):395-404. PubMed ID: 33073529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-drug conjugate directed against the guanylyl cyclase antigen for the treatment of gastrointestinal malignancies.
    Almhanna K; Prithviraj GK; Veiby P; Kalebic T
    Pharmacol Ther; 2017 Feb; 170():8-13. PubMed ID: 27765652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Solid Tumor Treatment with Antibody-drug Conjugates Using Agent-Based Modeling: Considering the Role of a Carrier Dose and Payload Class.
    Calopiz MC; Linderman JJ; Thurber GM
    Pharm Res; 2024 May; ():. PubMed ID: 38806889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates.
    Jackson D; Atkinson J; Guevara CI; Zhang C; Kery V; Moon SJ; Virata C; Yang P; Lowe C; Pinkstaff J; Cho H; Knudsen N; Manibusan A; Tian F; Sun Y; Lu Y; Sellers A; Jia XC; Joseph I; Anand B; Morrison K; Pereira DS; Stover D
    PLoS One; 2014; 9(1):e83865. PubMed ID: 24454709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.